# COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1)

> **NCT00689767** · NA · TERMINATED · sponsor: **Atrium Medical Corporation** · enrollment: 103 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CINATRA™ Coronary Stent System
- **DEVICE:** CINATRA™ ISA 247 Coated Coronary Stent System

## Key facts

- **NCT ID:** NCT00689767
- **Lead sponsor:** Atrium Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2009-06
- **Final completion:** 2012-07
- **Target enrollment:** 103 (ACTUAL)
- **Why stopped:** Terminated ahead of schedule after completion of the 3-year follow-up time point due to Sponsor decision.
- **Last updated:** 2013-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689767, "COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00689767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*